Penserra Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$159K Buy
864
+720
+500% +$133K ﹤0.01% 672
2025
Q1
$30K Sell
144
-4,476
-97% -$933K ﹤0.01% 865
2024
Q4
$820K Buy
4,620
+4,476
+3,108% +$794K 0.02% 464
2024
Q3
$28K Hold
144
﹤0.01% 859
2024
Q2
$25K Hold
144
﹤0.01% 905
2024
Q1
$26K Sell
144
-8,025
-98% -$1.45M ﹤0.01% 894
2023
Q4
$1.27M Sell
8,169
-2,339
-22% -$362K 0.02% 339
2023
Q3
$1.57M Sell
10,508
-1,657
-14% -$247K 0.03% 287
2023
Q2
$1.64M Buy
12,165
+11,309
+1,321% +$1.52M 0.03% 321
2023
Q1
$136K Sell
856
-24,108
-97% -$3.83M ﹤0.01% 741
2022
Q4
$4.03M Buy
24,964
+23,230
+1,340% +$3.75M 0.09% 159
2022
Q3
$232K Buy
1,734
+1,446
+502% +$193K 0.01% 595
2022
Q2
$44K Sell
288
-2,824
-91% -$431K ﹤0.01% 926
2022
Q1
$503K Sell
3,112
-2,248
-42% -$363K 0.01% 496
2021
Q4
$724K Buy
5,360
+4,966
+1,260% +$671K 0.02% 450
2021
Q3
$41K Buy
394
+54
+16% +$5.62K ﹤0.01% 1102
2021
Q2
$38K Buy
+340
New +$38K ﹤0.01% 1058
2020
Q3
Sell
-3,390
Closed -$332K 927
2020
Q2
$332K Buy
+3,390
New +$332K 0.02% 423
2019
Q1
Sell
-357
Closed -$32K 712
2018
Q4
$32K Buy
+357
New +$32K ﹤0.01% 516
2018
Q3
Sell
-17,455
Closed -$1.62M 688
2018
Q2
$1.62M Buy
17,455
+17,134
+5,338% +$1.59M 0.1% 172
2018
Q1
$30K Buy
+321
New +$30K ﹤0.01% 459
2017
Q2
Sell
-2,162
Closed -$140K 520
2017
Q1
$140K Buy
2,162
+188
+10% +$12.2K 0.01% 268
2016
Q4
$123K Buy
1,974
+210
+12% +$13.1K 0.01% 307
2016
Q3
$111K Buy
1,764
+882
+100% +$55.5K 0.01% 260
2016
Q2
$55K Buy
882
+294
+50% +$18.3K 0.01% 329
2016
Q1
$33 Buy
588
+108
+23% +$6 ﹤0.01% 359
2015
Q4
$28K Buy
+480
New +$28K ﹤0.01% 348